FDA battles 'pay for delay' pharma deals; Kennedy re-files PHR incentives bill;

> The FDA is coming down hard on deals between pharma companies, known as "pay for delay," in which branded drug makers pay generic drug makers to hold off on making a generic version of their product. FiercePharma

> Rep. Patrick Kennedy (D-RI) has announced plans to re-file a bill that establishes payments of up to $3 per record for doctors whose patients establish personal health records. FierceHealthIT

> With their employers cutting benefits to keep solvent in the down economy, employees of small businesses may soon struggle to pay medical bills. Article

> Researchers have found that a mouse that makes twice the normal levels of a protein called Nrf2 is protected from Parkinson's disease. FierceBioResearcher

And Finally... What possessed this man to trap pigeons in his pants? Inquiring minds want to know. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.